On the public citation graph
The Rise and Fall of Gabapentin for Bipolar Disorder
0 signed · 77 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archgenpsychiatry.2009.46openalex-snapshot
Persisting Decline in Depression Treatment After FDA Warnings
inferredcites →https://doi.org/10.1001/archinte.159.16.1931openalex-snapshot
Randomized Double-blind Study Comparing the Efficacy of Gabapentin With Amitriptyline on Diabetic Peripheral Neuropathy Pain
inferredcites →https://doi.org/10.1001/archinte.166.9.1021openalex-snapshot
Off-label Prescribing Among Office-Based Physicians
inferredcites →https://doi.org/10.1001/archpsyc.1991.01810340047006openalex-snapshot
Carbamazepine Compared With Lithium in the Treatment of Mania
inferredcites →https://doi.org/10.1001/archpsyc.57.9.841openalex-snapshot
Efficacy of Olanzapine in Acute Bipolar Mania A Double-blind, Placebo-Controlled Study
inferredcites →https://doi.org/10.1001/archpsyc.61.5.442openalex-snapshot
The Effect of a Managed Behavioral Health Carve-Out on Quality of Carefor Medicaid Patients Diagnosed as Having Schizophrenia
inferredcites →https://doi.org/10.1001/archpsyc.64.4.466openalex-snapshot
Impact of Publicity Concerning Pediatric Suicidality Data on Physician Practice Patterns in the United States
inferredcites →https://doi.org/10.1001/jama.280.21.1837openalex-snapshot
Gabapentin for the Treatment of Postherpetic Neuralgia A Randomized Controlled Trial
inferredcites →https://doi.org/10.1002/pds.1051openalex-snapshot
An epidemiological investigation of off‐label anticonvulsant drug use in the Georgia Medicaid population
inferredcites →https://doi.org/10.1007/s10488-006-0045-3openalex-snapshot
Schizophrenia, Co-occurring Substance use Disorders and Quality of Care: The Differential Effect of a Managed Behavioral Health Care Carve-out
inferredcites →https://doi.org/10.1016/0005-7967(91)90087-jopenalex-snapshot
Manic-depressive illness
inferredcites →https://doi.org/10.1016/j.qref.2004.05.003openalex-snapshot
Quality-constant “prices” for the ongoing treatment of schizophrenia: an exploratory study
inferredcites →https://doi.org/10.1016/s0048-7333(99)00092-xopenalex-snapshot
Models of technology diffusion
inferredcites →https://doi.org/10.1016/s0140-6736(03)14546-1openalex-snapshot
From best evidence to best practice: effective implementation of change in patients' care
inferredcites →https://doi.org/10.1016/s0163-8343(99)00057-2openalex-snapshot
The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO
inferredcites →https://doi.org/10.1016/s0304-3959(02)00255-5openalex-snapshot
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1034/j.1399-5618.2000.20305.xopenalex-snapshot
Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1
inferredcites →https://doi.org/10.1056/nejm199506153322406openalex-snapshot
Effect of a Prior-Authorization Requirement on the Use of Nonsteroidal Antiinflammatory Drugs by Medicaid Patients
inferredcites →https://doi.org/10.1056/nejmsa012075openalex-snapshot
Promotion of Prescription Drugs to Consumers
inferredcites →https://doi.org/10.1080/10673220216217openalex-snapshot
A Review of Quantitative Studies of Adherence to Mental Health Clinical Practice Guidelines
inferredcites →https://doi.org/10.1097/00004714-200012000-00004openalex-snapshot
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
inferredcites →https://doi.org/10.1097/01.mlr.0000215890.30756.b2openalex-snapshot
The Impact of Parity on Major Depression Treatment Quality in the Federal Employees’ Health Benefits Program After Parity Implementation
inferredcites →https://doi.org/10.1097/01.mlr.0000218775.04675.fdopenalex-snapshot
Prior Authorization Policies for Selective Cyclooxygenase-2 Inhibitors in Medicaid
inferredcites →https://doi.org/10.1097/mlr.0b013e31818475b7openalex-snapshot
Changes Over Time and Disparities in Schizophrenia Treatment Quality
inferredcites →https://doi.org/10.1097/mlr.0b013e3181adcc4fopenalex-snapshot
Longitudinal Racial/Ethnic Disparities in Antimanic Medication Use in Bipolar-I Disorder
inferredcites →https://doi.org/10.1111/j.1475-6773.2007.00766.xopenalex-snapshot
Impact of Medicaid Prior Authorization Requirement for COX‐2 Inhibitor Drugs in Nebraska
inferredcites →https://doi.org/10.1176/ajp.149.1.108openalex-snapshot
A double-blind comparison of valproate and lithium in the treatment of acute mania
inferredcites →https://doi.org/10.1176/ajp.2007.164.2.206openalex-snapshot
Measuring the Impact of Medical Research: Moving From Outputs to Outcomes
inferredcites →https://doi.org/10.1176/ajp.2007.164.6.884openalex-snapshot
Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs
inferredcites →https://doi.org/10.1176/appi.ajp.159.1.1openalex-snapshot
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
inferredcites →https://doi.org/10.1176/appi.ps.58.6.848openalex-snapshot
Quality of Care in a Medicaid Population With Bipolar I Disorder
inferredcites →https://doi.org/10.1176/foc.1.1.64openalex-snapshot
Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
inferredcites →https://doi.org/10.1176/ps.2007.58.1.27openalex-snapshot
Changes in the Quality of Care for Bipolar I Disorder During the 1990s
inferredcites →https://doi.org/10.1176/ps.49.8.1072openalex-snapshot
The Treated Prevalence of Bipolar Disorder in a Large Staff-Model HMO
inferredcites →https://doi.org/10.1192/bjp.187.3.229openalex-snapshot
Risperidone in the treatment of acute mania
inferredcites →https://doi.org/10.1371/journal.pmed.0040134openalex-snapshot
Characteristics and Impact of Drug Detailing for Gabapentin
inferredcites →https://doi.org/10.1377/hlthaff.23.1.135openalex-snapshot
Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid
inferredcites →https://doi.org/10.1377/hlthaff.23.5.210openalex-snapshot
Listening To Generic Prozac: Winners, Losers, And Sideliners
inferredcites →https://doi.org/10.1377/hlthaff.27.3.w185openalex-snapshot
Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change
inferredcites →https://doi.org/10.18553/jmcp.2002.8.4.266openalex-snapshot
Gabapentin Use in a Managed Medicaid Population
inferredcites →https://doi.org/10.18553/jmcp.2003.9.6.559openalex-snapshot
Examination of the Evidence for Off-Label Use of Gabapentin
inferredcites →https://doi.org/10.2307/2531248openalex-snapshot
Longitudinal Data Analysis for Discrete and Continuous Outcomes
inferredcites →https://doi.org/10.4088/jcp.v59n0405openalex-snapshot
Medication Compliance Among Patients With Bipolar Disorder and Substance Use Disorder
inferredcites →https://doi.org/10.4088/jcp.v60n0203openalex-snapshot
A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
inferredcites →https://doi.org/10.4088/jcp.v63n0502openalex-snapshot
Nonadherence With Mood Stabilizers
inferredcites →https://doi.org/10.4088/jcp.v66n0116openalex-snapshot
A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder
inferredcites →https://doi.org/10.7326/0003-4819-145-4-200608150-00008openalex-snapshot
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.2911372openalex-extracted
Relinquishment of Inappropriate Off-Label Uses: The Effect of the False Claims Act
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.45677openalex-snapshot
Disruptions in Care for Medicare Beneficiaries With Severe Mental Illness During the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1002/pds.3272openalex-snapshot
Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory
inferred← citeshttps://doi.org/10.1002/pds.3366openalex-snapshot
Increasing use of atypical antipsychotics and anticonvulsants during pregnancy
inferred← citeshttps://doi.org/10.1007/978-1-4614-2012-5_7openalex-snapshot
A Practitioner’s Guide to Prescribing Gabapentin for Adults with Intellectual Disabilities
inferred← citeshttps://doi.org/10.1007/978-3-031-85519-1_25openalex-snapshot
What Not to Use in the Pharmacological Treatment of Bipolar Disorder
inferred← citeshttps://doi.org/10.1007/s11019-012-9391-yopenalex-snapshot
Of mugs, meals and more: the intricate relations between physicians and the medical industry
inferred← citeshttps://doi.org/10.1007/s40263-013-0067-9openalex-snapshot
Publication Bias, with a Focus on Psychiatry: Causes and Solutions
inferred← citeshttps://doi.org/10.1016/j.jad.2021.11.007openalex-snapshot
What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines
inferred← citeshttps://doi.org/10.1016/j.sapharm.2013.11.001openalex-snapshot
National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning
inferred← citeshttps://doi.org/10.1016/j.yebeh.2011.03.011openalex-snapshot
Antiepileptic drugs in the treatment of psychiatric disorders
inferred← citeshttps://doi.org/10.1055/s-0036-1584935openalex-snapshot
The Effects of Antiepileptic Drugs on Pediatric Cognition, Mood, and Behavior
inferred← citeshttps://doi.org/10.1097/mlr.0b013e3181d60408openalex-snapshot
Clinical Prescribing (and Off-Label Use) in a Second-Best World
inferred← citeshttps://doi.org/10.1109/ijcnn48605.2020.9206668openalex-snapshot
Modeling Pharmacological Effects with Multi-Relation Unsupervised Graph Embedding
inferred← citeshttps://doi.org/10.1109/ijcnn55064.2022.9892375openalex-snapshot
Drug Repurposing Opportunities in Shapley Space
inferred← citeshttps://doi.org/10.1111/j.1476-5381.2011.01318.xopenalex-snapshot
Predictive animal models of mania: hits, misses and future directions
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-010814-124614openalex-snapshot
How Good Is “Evidence” from Clinical Studies of Drug Effects and Why Might Such Evidence Fail in the Prediction of the Clinical Utility of Drugs?
inferred← citeshttps://doi.org/10.1176/appi.ps.202000338openalex-snapshot
Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011–2016
inferred← citeshttps://doi.org/10.1177/0269216312464263openalex-snapshot
Off-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors
inferred← citeshttps://doi.org/10.1177/1178221818801311openalex-snapshot
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
inferred← citeshttps://doi.org/10.1179/107735211799030988openalex-snapshot
Corporate versus Public Interests: Community Responsibility to Defend Scientific Integrity
inferred← citeshttps://doi.org/10.1186/s12888-021-03533-3openalex-snapshot
Trends in antipsychotic prescribing for approved and unapproved indications to Medicaid-enrolled youth in Philadelphia, Pennsylvania between 2014 and 2018
inferred← citeshttps://doi.org/10.1377/hlthaff.2011.0370openalex-snapshot
False Claims Act Prosecution Did Not Deter Off-Label Drug Use In The Case Of Neurontin
inferred← citeshttps://doi.org/10.2147/jpr.s221579openalex-snapshot
Pain And The Use Of Gabapentinoids In German Nursing Home Residents - Results From An Analysis Based On Statutory Health Insurance Data
inferred← citeshttps://doi.org/10.3389/fpsyt.2019.00228openalex-snapshot
Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review
inferred← citeshttps://doi.org/10.4088/pcc.15r01821openalex-snapshot
Gabapentin Therapy in Psychiatric Disorders
inferred← citeshttps://doi.org/10.4103/0259-1162.94758openalex-snapshot
Comparison between preemptive gabapentin and paracetamol for pain control after adenotonsillectomy in children
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.